Endologix

About:

Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.

Website: http://www.endologix.com

Twitter/X: endologix

Top Investors: Deerfield, Greenspring Associates, Essex Woodlands Healthcare Partners

Description:

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologix's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.